18.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BAX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$17.75
Offen:
$17.83
24-Stunden-Volumen:
4.94M
Relative Volume:
0.73
Marktkapitalisierung:
$9.27B
Einnahmen:
$10.89B
Nettoeinkommen (Verlust:
$-241.00M
KGV:
-67.87
EPS:
-0.2656
Netto-Cashflow:
$340.00M
1W Leistung:
+0.55%
1M Leistung:
-17.82%
6M Leistung:
-41.62%
1J Leistung:
-47.28%
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Vergleichen Sie BAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BAX
Baxter International Inc
|
18.04 | 9.12B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
573.35 | 204.26B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
187.23 | 52.06B | 21.84B | 1.68B | 2.55B | 5.8322 |
|
RMD
Resmed Inc
|
252.89 | 36.51B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
ALC
Alcon Inc
|
77.75 | 36.78B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
277.99 | 19.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-31 | Herabstufung | Argus | Buy → Hold |
| 2025-08-04 | Herabstufung | Stifel | Buy → Hold |
| 2025-08-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-02-26 | Fortgesetzt | Goldman | Buy |
| 2025-02-24 | Hochstufung | Argus | Hold → Buy |
| 2025-02-20 | Fortgesetzt | Barclays | Overweight |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Recover Investment Losses: Class Action Initiated Against Baxter International, Inc. (BAX) - Newsfile
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm - PR Newswire
BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - MarketScreener
The Gross Law Firm Reminds Baxter International, Inc. - GlobeNewswire
Key facts: Baxter International halts Novum LVP shipments; faces lawsuit - TradingView
Deadline Alert: Baxter International, Inc. (BAX) - GlobeNewswire
Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the Firm - GlobeNewswire
Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the Firm - GlobeNewswire Inc.
The Gross Law Firm Reminds Baxter International, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025BAX - MarketScreener
Lost Money on Baxter International, Inc. (BAX)? Join Class Action Before December 15, 2025Contact Levi & Korsinsky - Newsfile
BAXTER INTERNATIONAL INC. (NYSE: BAX) DEADLINE ALERT - GlobeNewswire
How Baxter International Inc. stock performs in weak economyTrade Ideas & Detailed Earnings Play Alerts - newser.com
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit - PR Newswire
Is Baxter International Inc. stock a good choice for value investorsJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com
BAX ALERT: Securities Fraud Class Action Launched Against Baxter International, Inc.December 15, 2025 Deadline - Stockhouse
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages - GlobeNewswire
Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) ... - Black Hills Pioneer
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International - Morningstar
Fund Update: 18,050,555 BAXTER INTERNATIONAL (BAX) shares added to PZENA INVESTMENT MANAGEMENT LLC portfolio - Quiver Quantitative
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Baxter International downgraded to ’BBB-’ by S&P on weak performance - Investing.com India
Your Guide to the Baxter International, Inc. LawsuitA SueWallSt Podcast From Levi & Korsinsky - ACCESS Newswire
The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University - Business Wire
Investor Alert: Deadline Approaching to Join Baxter International, Inc. (BAX) Class ActionContact Levi & Korsinsky - Stockhouse
Lawsuit filed for Investors who lost money with shares of Baxter International Inc. (NYSE: BAX) - openPR.com
Baxter International, Inc. DEADLINE ALERT: Baxter International, Inc. Investors Urged to Contact Kirby McInerney LLP About Class Action Lawsuit - MarketScreener
Shareholders that lost money on Baxter International, Inc. (BAX) should contact Levi & ... - Bluefield Daily Telegraph
Key facts: Baxter Q3 2025 earnings miss expectations; class action lawsuit filed - TradingView
Baxter International, Inc. (BAX) Investors: December 15, 2025 Filing Deadline in Securities Class ActionContact Lieff Cabraser - ACCESS Newswire
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Baxter International - The AI Journal
Baxter advances patient blood management with Floseal - BioWorld MedTech
Multi factor analysis applied to Baxter International Inc.2025 Buyback Activity & Daily Profit Focused Screening - newser.com
BAX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Baxter International, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Levi & Korsinsky Urges Baxter International, Inc. (BAX) Shareholders to Act Before Lead Plaintiff Deadline December 15, 2025 - The Globe and Mail
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Baxter International, Inc.(BAX) Shareholders - Morningstar
2025-11-06 | BAX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Baxter International, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! | NYSE:BAX | Press Release - Stockhouse
Will Baxter International Inc. stock outperform tech sector in 20252025 Market Trends & Safe Investment Capital Preservation Plans - Fundação Cultural do Pará
Why Baxter International Inc. stock is listed among top recommendations2025 AllTime Highs & Accurate Buy Signal Notifications - Fundação Cultural do Pará
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Baxter International Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
BAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Baxter International, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Will Baxter International Inc. (BTL) stock justify high valuationWeekly Trade Report & Low Drawdown Investment Strategies - Fundação Cultural do Pará
Baxter International (NYSE:BAX) Sets New 52-Week LowHere's Why - MarketBeat
Day 6 of Loss Streak for Baxter International Stock with -23% Return (vs. -37% YTD) [11/4/2025] - Trefis
Bank of New York Mellon Corp Has $399.36 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
Baxter International Inc. stock trend outlook and recovery path2025 Major Catalysts & Breakout Confirmation Trade Signals - newser.com
How high can Baxter International Inc. stock go2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Why Baxter International (BAX) Is Down 21.5% After Novum Infusion Pump Disruptions and Lawsuits - simplywall.st
How Baxter International Inc. (BTL) stock trades after rate cutsMarket Risk Report & Free High Accuracy Swing Entry Alerts - newser.com
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):